Valo Therapeutics raised €19M in a funding round in Mar 2025. The company is based in Helsinki, Finland. Investors in the round: CDP Venture Capital Sgr, ENEA Tech e Biomedical, Freeman Road and 1 other. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €19M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
